PeterBlankestijn University Medical Center UtrechtNetherlands

Upload Picture

https://storage.unitedwebnetwork.com/files/1099/37dae05e719342238f707e8361ef1323.jpg

First Name

Peter

Last Name

Blankestijn

Institution

Country.

Netherlands

Time	Session

9:45 a.m. 11:15 a.m.	HIT! High Impact Clinical Trials DavidWheeler Chair University College LondonUnited Kingdom What Have We Learned From CONVINCE? PeterBlankestijn Oral Abstract Presenter P.J.Blankestijn@umcutrecht.nlUniversity Medical Center UtrechtNetherlands Design of the ZEUS Trial: Interleukin-6 Inhibition With Ziltivekimab for Cardiovascular Protection in Chronic Kidney Disease VladoPerkovic Oral Abstract Presenter vlado.perkovic@unsw.edu.auUniversity of New South Wales, Sydney, AustraliaAustralia A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN) JonathanBarratt Oral Abstract Presenter University of Leicester, Leicester, UKUnited Kingdom Observational Cohort With Embedded Randomized Controlled Trials to Study Pregnancy-Associated Progression of Renal Disease: A Feasibility Study of Dietary Nitrate (Beetroot Juice) to Protect Kidney Function in Pregnant Women With Chronic Kidney Disease PriscillaSmith Oral Abstract Presenter priscilla.smith@kcl.ac.ukKings College Hospital LondonUnited Kingdom Design of Randomized Embedded Adaptive Platform Clinical Trial in South Asian Kidney Biopsy-Proven Primary Glomerular Diseases: Multi-Center, Multi-Arm and Multi-Stage Selvin Sundar RajMani Oral Abstract Presenter selvinsr@gmail.comIndia SuceenaAlexander Oral Abstract Presenter Christian Medical College VelloreIndia Auditorium Brahmkamal Hall

Time

Session

9:45 a.m.

11:15 a.m.

HIT! High Impact Clinical Trials

DavidWheeler Chair University College LondonUnited Kingdom

What Have We Learned From CONVINCE?

PeterBlankestijn Oral Abstract Presenter P.J.Blankestijn@umcutrecht.nlUniversity Medical Center UtrechtNetherlands
Design of the ZEUS Trial: Interleukin-6 Inhibition With Ziltivekimab for Cardiovascular Protection in Chronic Kidney Disease

VladoPerkovic Oral Abstract Presenter vlado.perkovic@unsw.edu.auUniversity of New South Wales, Sydney, AustraliaAustralia
A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN)

JonathanBarratt Oral Abstract Presenter University of Leicester, Leicester, UKUnited Kingdom
Observational Cohort With Embedded Randomized Controlled Trials to Study Pregnancy-Associated Progression of Renal Disease: A Feasibility Study of Dietary Nitrate (Beetroot Juice) to Protect Kidney Function in Pregnant Women With Chronic Kidney Disease

PriscillaSmith Oral Abstract Presenter priscilla.smith@kcl.ac.ukKings College Hospital LondonUnited Kingdom
Design of Randomized Embedded Adaptive Platform Clinical Trial in South Asian Kidney Biopsy-Proven Primary Glomerular Diseases: Multi-Center, Multi-Arm and Multi-Stage

Selvin Sundar RajMani Oral Abstract Presenter selvinsr@gmail.comIndia

SuceenaAlexander Oral Abstract Presenter Christian Medical College VelloreIndia

Auditorium Brahmkamal Hall